|
14.03.2012
His scientific curiosity was first awakened by a trip to the cinema. Today, the neurologist Günter Höglinger is dedicated to one of the greatest mysteries of medicine: the causes of Parkinson's disease.
|
|
08.02.2012
Sven Kerzenmacher researches biofuels at Freiburg's Institute for Microsystem Technology. Whether the electrical current is obtained from glucose or water is all equally interesting for the keen scientist.
|
|
11.01.2012
Biologist Matthias Kieslinger arrived at cancer research through the analysis of blood stem cells in bone marrow. Running like a thread through the career of the Austrian-born scientist is the early B cell factor (EBF).
|
|
16.12.2011
Gunter Meister is investigating whether microRNAs could be used to eliminate dangerous dormant cancer stem cells. The biochemist is a professor at the Institute of Biochemistry, Genetics and Microbiology at the University of Regensburg.
|
|
26.10.2011
Cordian Beyer, a researcher at its Institute of Neuroanatomy at the RWTH Aachen is researching a hormone therapy for stroke and multiple sclerosis patients.
|
|
15.10.2011
Christoph Kaleta’s work is about understanding the metabolic processes that take place in organisms. The just 28 year-old systems biologist in Jena has the big picture in mind.
|
|
23.09.2011
Alexander Knoll is the founder of the Berlin-based biotechnology company BioGenes. After a turbulent beginning for his firm in the post-wall era, BioGenes is now on the path towards world market leadership in quality assurance assays.
|
|
25.08.2011
The proteins in cell walls and membranes run like a red thread through Dirk Linke’s research career. The scientist at the Max Planck Institute for Developmental Biology in Tübingen is investigating structures found on the surfaces of related bacteria. The work is part of a targeted search for new vaccines.
|
|
02.08.2011
Axel Ullrich is a pioneer in cancer research, as well as the founder of four different biotechnology companies. The research work by the Head of the Department of Molecular Biology at the Max Planck Institute for Biochemistry has resulted in four approved cancer drugs.
|
|
21.06.2011
Thomas Eschenhagen is reconstructing the heart in order to understand it in detail. The heart specialist is also spokesperson for the new German Center for Cardiovascular Research.
|
